U

Active Director Director DIN 09763051
DIN 09763051 First appointment Oct 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2022
Shareholding value •••• Premium profile

About Urmila

Data last updated:

Urmila is a Director at Perumal Medicals Private Limited (since 2022). The company operates in Chemicals. Perumal Medicals Private Limited reported revenue of ₹62.7 Lakh (FY 2024).

DIN 09763051
Primary Designation Director
Industry Chemicals
First Appointment 12 Oct 2022
Oldest Company Age 4 yrs
Largest company Perumal Medicals Private Limited · ₹62.7 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Perumal Medicals Private Limited U24239HR2022PTC107131
Director12 Oct 20222022₹62.7 Lakh (FY 2024)Active

Board colleagues of Urmila

NameDINCompanyDesignation
Gajender Kodan06405350Perumal Medicals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Perumal Medicals Private Limited
Premium access

Shareholding and investment profile for Urmila

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Urmila

Urmila currently holds 1 directorship: Perumal Medicals Private Limited (Director, since 12 Oct 2022, revenue ₹62.7 Lakh (FY 2024)).

Urmila was first appointed on 12 Oct 2022 as Director at Perumal Medicals Private Limited.

The current boards of Urmila's companies include Gajender Kodan (Perumal Medicals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available